Dataset Information


Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with NonSmall Cell Lung Cancer.

ABSTRACT: We report a 29-gene diagnostic signature, which distinguishes individuals with NSCLC from controls with non-malignant lung disease with 91% Sensitivity, 79% Specificity and a ROC AUC of 92%. Accuracy on an independent set of 18 NSCLC samples from the same location was 79%. Samples from an independent location including 12 stage 1 NSCLC and 15 controls, achieved an accuracy of 74%. A study of 18 paired samples taken pre and post surgery shows that the PBMC associated “cancer” signature is significantly reduced after tumor removal, supporting the hypothesis that the signature detected in pre-surgery samples is a response to the presence of the tumor. Overall design: We compared microarray gene expression profiles in PBMC from patients with NSCLC and a control group with smoking-related non-malignant lung disease, a likely confounding factor. We found a distinguishing gene signature which was validated on 2 independent sets of hold-out samples one set from a different location. Gene expression changes were also compared between pre and post surgery samples from 18 patients.

INSTRUMENT(S): Illumina human-6 v2.0 expression beadchip

ORGANISM(S): Homo sapiens  

SUBMITTER: Louise C Showe  




Similar Datasets

2010-04-09 | E-GEOD-13255 | ArrayExpress
2011-12-01 | E-GEOD-27606 | ArrayExpress
2011-12-01 | GSE27606 | GEO
| GSE102459 | GEO
2009-03-04 | GSE15081 | GEO
2010-05-23 | E-GEOD-15081 | ArrayExpress
2010-07-30 | E-GEOD-21521 | ArrayExpress
2016-02-11 | E-GEOD-77803 | ArrayExpress
2010-06-25 | GSE21521 | GEO
| GSE74948 | GEO